Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$33.58 - $41.2 $19 Million - $23.3 Million
566,095 New
566,095 $20.2 Billion
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $21.3 Million - $26.7 Million
573,798 New
573,798 $21.7 Million
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $3.14 Million - $4.18 Million
-85,903 Reduced 12.91%
579,413 $25.6 Million
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $3.68 Million - $4.99 Million
116,069 Added 21.13%
665,316 $24.6 Million
Q1 2022

May 11, 2022

SELL
$29.88 - $37.04 $219,020 - $271,503
-7,330 Reduced 1.32%
549,247 $20.3 Million
Q4 2021

Feb 11, 2022

SELL
$25.61 - $35.1 $102,158 - $140,013
-3,989 Reduced 0.71%
556,577 $16.9 Million
Q3 2021

Nov 12, 2021

BUY
$33.54 - $40.55 $672,040 - $812,500
20,037 Added 3.71%
560,566 $18.8 Million
Q2 2021

Aug 11, 2021

SELL
$34.54 - $47.25 $157,813 - $215,885
-4,569 Reduced 0.84%
540,529 $21.6 Million
Q1 2021

May 13, 2021

SELL
$42.51 - $63.78 $1.06 Million - $1.59 Million
-24,896 Reduced 4.37%
545,098 $24.5 Million
Q4 2020

Feb 09, 2021

BUY
$45.3 - $60.27 $1.03 Million - $1.36 Million
22,638 Added 4.14%
569,994 $32.2 Million
Q3 2020

Nov 12, 2020

SELL
$47.45 - $62.95 $365,602 - $485,029
-7,705 Reduced 1.39%
547,356 $26 Million
Q2 2020

Aug 12, 2020

BUY
$46.85 - $61.05 $51,113 - $66,605
1,091 Added 0.2%
555,061 $32.7 Million
Q1 2020

May 06, 2020

SELL
$41.6 - $63.4 $823,846 - $1.26 Million
-19,804 Reduced 3.45%
553,970 $26.2 Million
Q4 2019

Feb 14, 2020

BUY
$53.85 - $65.27 $1.43 Million - $1.73 Million
26,539 Added 4.85%
573,774 $34.7 Million
Q3 2019

Nov 07, 2019

BUY
$59.06 - $72.15 $106,308 - $129,870
1,800 Added 0.33%
547,235 $32.8 Million
Q2 2019

Aug 12, 2019

BUY
$62.09 - $86.14 $1.64 Million - $2.27 Million
26,378 Added 5.08%
545,435 $35.1 Million
Q1 2019

May 14, 2019

SELL
$52.92 - $81.17 $594,027 - $911,133
-11,225 Reduced 2.12%
519,057 $42.1 Million
Q4 2018

Feb 11, 2019

BUY
$43.37 - $59.54 $103,220 - $141,705
2,380 Added 0.45%
530,282 $28.7 Million
Q3 2018

Nov 09, 2018

BUY
$42.88 - $53.7 $374,814 - $469,391
8,741 Added 1.68%
527,902 $0
Q2 2018

Aug 06, 2018

SELL
$40.53 - $50.7 $935,675 - $1.17 Million
-23,086 Reduced 4.26%
519,161 $21.6 Million
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $60,389 - $75,418
1,370 Added 0.25%
542,247 $23.9 Million
Q4 2017

Feb 09, 2018

BUY
$50.3 - $64.39 $27.2 Million - $34.8 Million
540,877
540,877 $27.2 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.